Iloprost in COVID-19: The Rationale of Therapeutic Benefit
Front Cardiovasc Med
.
2021 Apr 23:8:649499.
doi: 10.3389/fcvm.2021.649499.
eCollection 2021.
Authors
Paola Maria Faggioli
1
,
Nicola Mumoli
2
,
Antonino Mazzone
1
Affiliations
1
Internal Medicine Azienda Socio Sanitaria Territoriale OVEST Milanese, Legnano Hospital, Milan, Italy.
2
Internal Medicine Azienda Socio Sanitaria Territoriale OVEST Milanese, Magenta Hospital, Milan, Italy.
PMID:
33969013
PMCID:
PMC8102696
DOI:
10.3389/fcvm.2021.649499
No abstract available
Keywords:
COVID-19; iloprost; inflammation; therapy; thrombosis.